Nephrol Dial Transplant (2000) 15: 224-230
© 2000 European Renal Association-European Dialysis and Transplant Association
Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study
1 Department of Nephrology, Dialysis and Transplantation and 2 Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Belgium
Correspondence and offprint requests to: Karine Gastaldello, Department of Nephrology, Hôpital Erasme, 808 Route de Lennik, B-1070 Brussels, Belgium.
Background. Whether the nature of haemodialysis (HD) membranes can influence the outcome of acute renal failure (ARF) remains debatable. Recent studies have suggested that dialysis with bioincompatible unsubstituted cellulosic membranes is associated with a less favourable patient outcome than dialysis with biocompatible synthetic membranes. Since we generally use a modified cellulosic membrane with substantially lower complement- and leukocyte-activating potential than cuprophane, for dialysis of patients with ARF, and because there are no data in the literature regarding the influence of modified cellulosic membranes on the outcome of patients with ARF, we compared the outcome of ARF patients dialysed either with cellulose diacetate or with a synthetic polysulfone membrane. We also investigated the potential role of permeability by comparing membranes with high-flux versus low-flux characteristics.
Methods. This prospective, randomized, single centre study included 159 patients with ARF requiring HD. Patients were stratified according to age, gender, and APACHE II score and then randomized in chronological order to one of three dialysis membranes: low-flux polysulfone, high-flux polysulfone and meltspun cellulose diacetate.
Results. Aetiologies of ARF and the prevalence of oliguria were similarly distributed among the three groups. There was no significant difference between the three groups for survival (multivariate Cox's proportional hazards model, P=0.57), time necessary to recover renal function (P=0.82), and number of dialysis sessions required before recovery (P=0.86). Multivariate analysis showed that survival was significantly influenced only by the severity of the disease state (APACHE III score, P<0.0001), but not by the nature of the dialysis membrane (P=0.57) or the presence of oliguria (P=0.24).
Conclusions. Among patients with ARF requiring HD survival and recovery time are not significantly influenced by the use of either meltspun cellulose diacetate or the more biocompatible high-flux or low-flux polysulfone. Dialysis using modified cellulose membranes is just as effective as dialysis using synthetic polysulfone membranes, but at a lower cost. In addition, the flux of the membrane did not influence patient outcome.
Keywords: acute renal failure; biocompatibility; dialysis membrane; haemodialysis; sepsis; survival
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Pannu, S. Klarenbach, N. Wiebe, B. Manns, M. Tonelli, and for the Alberta Kidney Disease Network Renal Replacement Therapy in Patients With Acute Renal Failure: A Systematic Review JAMA, February 20, 2008; 299(7): 793 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Cho, J. Himmelfarb, E. Paganini, T. A. Ikizler, S. H. Soroko, R. L. Mehta, and G. M. Chertow Survival by Dialysis Modality in Critically Ill Patients with Acute Kidney Injury J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3132 - 3138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gill, J. V. Nally Jr, and R. A. Fatica Renal Failure Secondary to Acute Tubular Necrosis: Epidemiology, Diagnosis, and Management Chest, October 1, 2005; 128(4): 2847 - 2863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Teehan, O. Liangos, and B. L. Jaber Update on Dialytic Management of Acute Renal Failure J Intensive Care Med, May 1, 2003; 18(3): 130 - 138. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L. Esson and R. W. Schrier Diagnosis and Treatment of Acute Tubular Necrosis Ann Intern Med, November 5, 2002; 137(9): 744 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Stamatakis Strategies for Treatment and Prevention of Acute Renal Failure Journal of Pharmacy Practice, October 1, 2002; 15(5): 392 - 404. [Abstract] [PDF]
|
|